Loading...
OLED Fab Timing Risks And Blue Emitter Delays Will Eventually Reward Patient Belief
AN
AnalystLowTarget
Not Invested
Community Contributor
Published
28 Jan 26
Views
14
28 Jan
US$87.16
AnalystLowTarget's Fair Value
US$130.00
33.0% undervalued intrinsic discount1Y
-44.2%7D
-2.0%1Y
-44.2%7D
-2.0%Author's Valuation
US$13033.0% undervalued intrinsic discount
AnalystLowTarget Fair Value